Announcements Trials
Browse Landscape

Phase

Phase 3 7Phase 4 4Phase 2 3Phase 1 2

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Conditions

Leiomyoma 1Dupuytren Contracture 1

Interventions

Paclitaxel 291Gemcitabine 254Carboplatin 253Cisplatin 250Radiotherapy 219Cyclophosphamide 218Irinotecan 184pembrolizumab 180Docetaxel 174Bevacizumab 166Capecitabine 148Nivolumab 141Fluorouracil 132Dexamethasone 125Bortezomib 123Oxaliplatin 115Cytarabine 113Erlotinib Hydrochloride 112Sorafenib 110Temozolomide 109Doxorubicin 106Rituximab 105Leucovorin 105Etoposide 105Filgrastim 99Everolimus 97Lenalidomide 95Ipilimumab 90Pemetrexed 89fludarabine phosphate 84

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Completed × Microbial Collagenase × Clear all
NCT02889848 2019-07-10

Safety and Tolerability of Collagenase Clostridium Histolyticum (EN3835) to Treat Uterine Leiomyoma (Fibroids)

Advance Biofactures Corporation

Phase 1 Completed
15 enrolled

Leiomyoma

NCT00528931 2017-10-05

A Pharmacokinetic Study of AA4500 (XIAFLEXâ„¢, Proposed Name) in Subjects With Dupuytren's Contracture

Endo Pharmaceuticals

Phase 1 Completed
16 enrolled 11 charts

Dupuytren Contracture

Data powered by HemOnc (CC BY 4.0) Colophon âš¡